METROPOLIS: DIAGNOSTICS BUSINESS SHOWS PROFIT GROWTH

Healthcare reported a strong improvement in its September-quarter profitability. Q2 FY27 net profit increased 41.5% year-on-year to approximately ₹75 crore. The diagnostics business is supported by preventive healthcare, medical testing demand, laboratory networks and specialised testing services. What investors should monitor: - Test volumes and patient growth - Revenue per patient - Network expansion - Specialty testing contribution - Operating margins and acquisition integration My view: Growth in preventive healthcare and specialised diagnostics can support the sector. However, investors should examine whether volume growth is translating into consistent profitability and cash generation.